Sabra Health Care REIT, Inc. (SBRA) P/E Ratio History
Historical price-to-earnings valuation from 2011 to 2026
Loading P/E history...
SBRA Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Sabra Health Care REIT, Inc. (SBRA) trades at a price-to-earnings ratio of 32.0x, with a stock price of $20.50 and trailing twelve-month earnings per share of $0.61.
The current P/E is 65% below its 5-year average of 90.8x. Over the past five years, SBRA's P/E has ranged from a low of 11.5x to a high of 765.3x, placing the current valuation at the 55th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.3x, SBRA trades at a 32% premium to its sector peers. The sector includes 170 companies with P/E ratios ranging from 1.1x to 195.0x.
Relative to the broader market, SBRA commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SBRA DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SBRA P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $152B | 155.7 | - | -11% | |
| $41B | 160.4 | - | +184%Best | |
| $14B | 23.7 | 1.02Best | +25% | |
| $2B | 15.3Lowest | - | +24% | |
| $9B | 25.1 | 1.19 | +96% | |
| $4B | 24.5 | - | -4% | |
| $14B | 195.0 | - | -72% | |
| $94M | 115.3 | - | -95% | |
| $500M | 226.2 | - | +134% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
SBRA Historical P/E Data (2011–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $19.23 | $0.63 | 30.4x | -45% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $18.94 | $0.64 | 29.5x | -46% |
| FY2025 Q3 | $18.64 | $0.72 | 25.8x | -53% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $18.44 | $0.76 | 24.3x | -56% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $17.47 | $0.59 | 29.6x | -46% |
| FY2024 Q4 | $17.32 | $0.53 | 32.7x | -41% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $18.61 | $0.41 | 45.0x | -18% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $15.40 | $0.22 | 70.5x | +28% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $14.77 | $0.21 | 70.5x | +28% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $14.27 | $0.06 | 243.9x | +344% |
| FY2022 Q2 | $13.97 | $0.19 | 72.6x | +32% | |
| FY2021 Q1 | Wed Mar 31 2021 00:00:00 GM | $17.36 | $0.66 | 26.3x | -52% |
Average P/E for displayed period: 54.9x
See SBRA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SBRA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SBRA vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonSBRA — Frequently Asked Questions
Quick answers to the most common questions about buying SBRA stock.
Is SBRA stock overvalued or undervalued?
SBRA trades at 32.0x P/E, below its 5-year average of 90.8x. At the 55th percentile of historical range, the stock is priced at a discount to its own history.
How does SBRA's valuation compare to peers?
Sabra Health Care REIT, Inc. P/E of 32.0x compares to sector median of 24.3x. The premium reflects expected growth above peers.
What is SBRA's PEG ratio?
SBRA PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2011-2026.